Glenn Jeffrey S 4
4 · Eiger BioPharmaceuticals, Inc. · Filed Mar 3, 2023
Insider Transaction Report
Form 4
Glenn Jeffrey S
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-03-01+28,000→ 28,000 totalExercise: $1.71Exp: 2033-02-28→ Common Stock (28,000 underlying)
Footnotes (1)
- [F1]The option vests in equal monthly installments over 12 months measured from March 1, 2023, subject to Reporting Person's continuous service status as of each such date.